Correlation Between Structure Therapeutics and Nurix Therapeutics

Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Structure Therapeutics American and Nurix Therapeutics, you can compare the effects of market volatilities on Structure Therapeutics and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Nurix Therapeutics.

Diversification Opportunities for Structure Therapeutics and Nurix Therapeutics

-0.63

Correlation Coefficient

Structure Therapeutics  Nurix Therapeutics

Excellent diversification

The 3 months correlation between Structure and Nurix is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Nurix Therapeutics go up and down completely randomly.

Pair Corralation between Structure Therapeutics and Nurix Therapeutics

Given the investment horizon of 90 days Structure Therapeutics American is expected to under-perform the Nurix Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Structure Therapeutics American is 1.38 times less risky than Nurix Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Nurix Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,116  in Nurix Therapeutics on May 1, 2025 and sell it today you would earn a total of  72.00  from holding Nurix Therapeutics or generate 6.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Structure Therapeutics America  vs.  Nurix Therapeutics

Structure Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in August 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Nurix Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Nurix Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Nurix Therapeutics may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Structure Therapeutics and Nurix Therapeutics

The main advantage of trading using opposite Structure Therapeutics and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.

The idea behind Structure Therapeutics American and Nurix Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.